Table 2.
Normal (n = 23) | Early-stage PD (n = 12) | Advanced-stage PD (n = 11) | Tests of homogeneity of variances P values | ANOVA |
Multiple comparisons P values (95% confidence interval) | ||||
---|---|---|---|---|---|---|---|---|---|
df | F | P values | |||||||
CEST/APT | MTRasym(3.5 ppm) | 1.25 ± 0.18 | 0.96 ± 0.14 | 0.81 ± 0.29 | 0.035 | 2 | 5.248 | 0.007 | 0.032 (0.02, 0.54), 0.599 (−0.23, 0.54), 0.032 (0.03, 0.84) |
3.45 ± 0.44 | 2.68 ± 0.50 | 2.21 ± 0.95 | 0.097 | 2 | 4.980 | 0.009 | 0.141 (−0.19, 1.73), 0.576 (−0.65, 1.59), 0.010 (0.26, 2.23) | ||
DTI | FA | 0.36 ± 0.02 | 0.34 ± 0.02 | 0.31 ± 0.03 | 0.790 | 2 | 9.630 | <0.001 | 0.149 (−0.01, 0.05), 0.072 (−0.01, 0.07), <0.001 (0.03, 0.09) |
MD | 0.68 ± 0.02 | 0.69 ± 0.03 | 0.70 ± 0.05 | 0.003 | 2 | 0.429 | 0.653 | 0.837 (−0.06, 0.04), 0.943 (−0.09, 0.07), 0.750 (−0.10, 0.05) |
MTRasym(3.5 ppm) was quantified by % water signal intensity. was defined as the integral of the MTRasym spectrum in the range of 0–4 ppm. FA, fractional anisotropy; MD, mean diffusivity. Three P values in multiple comparisons corresponded to the results between normal controls and early-stage PD patients, between early-stage and advanced-stage PD patients, as well as between normal controls and advanced-stage PD patients, respectively. Bold indicates significant change.